Cardiome Pharma Corporation (CRME)

Add to Watchlists Create an Alert
2.00 -0.02  -0.99%   NASDAQ May 22, 8:00PM BATS Real time Currency in USD

Cardiome Pharma Corporation SG&A Expense Quarterly:

2.356M for Dec. 31, 2012
View Full Chart

Cardiome Pharma Corporation SG&A Expense Quarterly Chart

    Cardiome Pharma Corporation Historical SG&A Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 2.356M
    Sept. 30, 2012 2.496M
    June 30, 2012 2.21M
    March 31, 2012 2.739M
    Dec. 31, 2011 2.095M
    Sept. 30, 2011 2.764M
    June 30, 2011 3.466M
    March 31, 2011 3.224M
    Dec. 31, 2010 2.74M
    Sept. 30, 2010 3.505M
    June 30, 2010 3.272M
    March 31, 2010 3.358M
    Dec. 31, 2009 3.367M
    Sept. 30, 2009 4.193M
    June 30, 2009 4.226M
    March 31, 2009 3.32M
    Dec. 31, 2008 1.510M
    Sept. 30, 2008 4.552M
    June 30, 2008 4.329M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Aug. 31, 2003 Go Pro
    May 31, 2003 Go Pro
    Feb. 28, 2003 Go Pro
    Nov. 30, 2002 Go Pro
    Aug. 31, 2002 Go Pro
    May 31, 2002 Go Pro
    Feb. 28, 2002 Go Pro
    Nov. 30, 2001 Go Pro
    Aug. 31, 2001 Go Pro
    May 31, 2001 Go Pro
    Feb. 28, 2001 Go Pro
    Nov. 30, 2000 Go Pro
    Aug. 31, 2000 Go Pro
    May 31, 2000 Go Pro

    About SG&A Expense

    SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

    The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
    Learn More

    Get data for

    CRME SG&A Expense Quarterly Benchmarks

    Companies
    Merrimack Pharmaceuticals 4.155M
    Chemocentryx 2.826M
    QLT 2.082M

    CRME SG&A Expense Quarterly Rankings

    Overall 48th percentile
    4115 of 8006
    Sector 35th percentile
    440 of 686 in Healthcare
    Industry 44th percentile
    137 of 248 in Biotechnology

    CRME SG&A Expense Quarterly Range, Past 5 Years

    Minimum 1.510M Dec 2008
    Maximum 4.552M Sep 2008
    Average 3.143M